Lenvatinib, tislelizumab, gemcitabine and cisplatin Clinical Trials
2 recruitingDrug
Phase 31Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 3
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT05823311
Recruiting
Phase 2
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
Advanced Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT05532059